http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CL-2016000988-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ca2e4410855da087e11bf3eea8933fa |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-044 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7042 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-50 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7042 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-04 |
| filingDate | 2016-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_332bfd9f6e8b872899d987f0818de269 |
| publicationDate | 2016-11-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CL-2016000988-A1 |
| titleOfInvention | Compounds derived from 1-isobutyl-3- [2- [4- [3- [4 - [[4-methyl-1 - [(2r, 3r, 4s, 5s, 6r) -3,4,5-trihydroxy- 6- (hydroxymethyl) tetrahydropyran-2-yl] indole-3-yl] methyl] -phenoxy] -propyl] -4,9-diazaspiro [5.5] -undecan-9-yl] -2-oxo-ethyl] urea or one of its salts, sglt inhibitor; pharmaceutical composition; and its use to treat type 1 and type 2 diabetes. |
| abstract | COMPOUND 1-ISOBUTIL-3- [2- [4- [3- [4 - [[4-METIL-1 - [(2R, 3R, 4S, 5S, 6R) -3,4,5-TRIHYDROXI-6- (HYDROXIMETHYL) TETRAHYDROPIRAN-2-IL] INDOL-3-IL] METHYL] PHENOXY] PROPIL] -4,9-DIAZAESPIRO [5.5] UNDECAN-9-IL] -2-OXO-ETIL] UREA OR ONE OF ITS SALTS, SGLT INHIBITOR; PHARMACEUTICAL COMPOSITION; AND ITS USE TO TREAT TYPE 1 AND TYPE 2 DIABETES. |
| priorityDate | 2013-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 27.